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Summary Chinese hamster ovary (CHO) cells were exposed in vitro to combinations of bleomycin and
misonidazole under hypoxic conditions. Only one drug was present at any given time and cells were washed
before being exposed to the second drug. Both drugs induced potentially lethal damage (PLD). This damage
was repaired under hypoxic conditions very rapidly, and bleomycin-induced PLD was repaired more rapidly
than misonidazole-induced PLD. If, after the combined treatment, cells are kept in hypoxia, much of the
damage can be repaired.
Misonidazole (MISO) has been extensively studied
as a radiosensitizer of hypoxic mammalian cells
(Adams, 1977) and it is currently being evaluated as
an adjunct to radiotherapy in a number of clinical
trials (Phillips et al., 1982). In the course of the
investigations of its effects in mammalian cells, it
was discovered that MISO is selectively toxic to
hypoxic mammalian cells (Hall &. Roizin-Towle,
1975; Moore et al., 1976). Furthermore, even under
conditions where MISO does not itself kill cells, the
drug inflicts damage in hypoxic cells which can
potentiate the radiosensitivity of those cells (Hall &
Biaglow, 1977; Wong et al., 1978). It has been
reported that MISO can also potentiate the effect
of chemotherapeutic agents (Roizin-Towle & Hall,
1978; Stratford et al., 1980). For example, Roizin-
Towle and Hall showed that inactivation of
hypoxic cells by bleomycin can be potentiated by
simultaneous treatment with MISO (Roizin-Towle
& Hall, 1978, 1981).
It has been suggested that MISO induces a form
of potentially lethal damage (PLD) similar to that
demonstrated for ionizing radiation (Korbelik et
al., 1981). Furthermore, it has been proposed that
the radiation-toxicity interaction occurs between
radiation-indiced PLD and MISO-induced PLD,
with both treatments affecting the same target.
Bleomycin, too, is a drug which is known to induce
PLD-like damage in mammalian cells (Hahn et al.,
1982). Furthermore, it was proposed that this PLD
involves DNA as a target molecule (Nakatsugawa et
al., 1984). Bleomycin and MISO are both known to
damage DNA (Kohn & Ewig, 1976; Palcic &
Skarsgard, 1978). Thus, we speculated that MISO-
bleomycin interactions may be via a mechanism
similar to the radiation-MISO interaction, with
each drug inflicting specific damage in the same
Correspondence: B. Palcic
Received 19 December, 1984.
c
target molecule, DNA. While damage induced by
bleomycin or MISO can be repaired to a large
extent when cells are treated by either drug alone, a
combined treatment of cells with both drugs
decreases the repairability of the target. When both
types of damage are present, the fidelity of repair
or the extent of repair may be affected, resulting in
decreased cell survival.
Materials and methods
Cells
Chinese hamster ovary (CHO) cells were grown in
spinner cultures at 37°C in alpha medium (GIBCO)
supplemented with 10% foetal calf serum (GIBCO).
Cells were maintained in logarithmic growth by
daily dilution to 10cellsml-1. The doubling time
was - 12lh.
Hypoxia
Hypoxia was obtained by flowing purified nitrogen
gas (<5 ppm 02, Canadian Liquid Air) over stirred
growth medium. The gas flow was - 11 min-1.
After medium containing the drug had been made
hypoxic (in -45min), cells were added in a small
volume of medium to give a final concentration of
1.5 x lO5cellsml-P. The time at which cells were
added to the hypoxic medium was taken as the
start of the hypoxic incubation with drug. To assess
colony forming ability, a sample of cell suspension
was withdrawn at a prescribed time, the cells were
washed and plated into 5cm plastic tissue culture
dishes (Falcon). Colonies containing 50 cells or
more after 7 days incubation were defined as
survivors.
Drugs
MISO (Roche) and bleomycin (Bristol) solutions
were freshly prepared in medium before each
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experiment. The drugs were diluted to the desired
concentration and the solutions were made hypoxic
(as described above) before the addition of cells. At
no time during these experiments were both drugs
used at the same time. Cells were always treated
first with one drug, and then after it was washed
away, the cells were exposed to the second drug.
During the washing procedure (centrifugation,
resuspension in growth medium) the cells were
under aerobic conditions, but were kept at 4°C. In
some experiments, actinomycin D (Sigma) was
substituted for bleomycin.
Bleomycin treatment was expressed in pgmlP' as
is customary through the literature, and MISO in
molar concentration. Molecular weight of MISO is
201.2 and thus 2mM and 5mM MISO corresponds
to 402.4pgml-1 and 1006.0jugml-', respectively.
Hypertonic treatment
In some experiments, the existence of potentially
lethal damage was investigated by treatment of cells
with hypertonic solution. In this case, the cells were
washed free of the drug under investigation and
then they were resuspended in hypertonic solution,
a
0.5M NaCl, phosphate buffered saline, pH=7.2,
for 20min at 370C. Immediately after hypertonic
treatment the cells were resuspended in growth
medium and plated.
Irradiation
Cells were irradiated under aerobic conditions
always prior to MISO toxicity studies. The cells
were suspended in growth medium and irradiated at
4°C to the desired dose of X-rays (270kVp, HVL
1.7mm Cu, 1.4Gymin-1). Immediately after
irradiation, the cells were made hypoxic and MISO
treatment started. Thus, no repair time was allowed
between irradiation and MISO exposure.
Results
It has been shown that ionizing radiation reduces
the zero-slope shoulder of the cell response to
MISO toxicity in hypoxia (Korbelik et al., 1981).
An example of this phenomenon is shown in Figure
la. Cells irradiated to a dose of 7.5Gy of X-rays,
have a shoulder width only 1/3 that of unirradiated
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Figure 1 Radiation-MISO and Bleomycin-MISO treatment (a) CHO cells were irradiated with X-rays to
7.5 Gy (A) and 11 Gy ('), and then exposed to MISO for the indicated times under hypoxia. Control cells
were not exposed to either bleomycin or radiation (0). (b) CHO cells were exposed to bleomycin,
100/gml-1 for 1 h at 37°C. After bleomycin was washed away, the cells were made hypoxic and exposed to
2mM MISO at 37°C for the indicated times (O) or they were kept in hypoxia without MISO (*).
Immediately after a sample of cell suspension was withdrawn, the cells were washed and plated. The dotted
lines are those from panel (a).
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cells; a dose of 11 Gy completely eliminated the
zero-slope shoulder.
Exposure of cells to bleomycin (100jMgml', 1 h
at 37°C) inactivates CHO cells to the same extent
as 11 Gy of X-rays. This treatment also affects the
response of surviving cells to MISO toxicity in
hypoxia. However, there are important differences
compared to the situation with X-rays, as can be
seen in Figure lb. Although the "shoulder" is
reduced somewhat by the bleomycin exposure, it is
still present; cells inactivated to the same survival
level by X-rays completely lost the shoulder. It is
clear that there is an initial increase in cell survival
under hypoxic incubation with or without MISO
present. Beyond 2h, survival decreases in the
presence of 2mM MISO. The initial increase was
absent for aerobic incubation.
The importance of the sequence by which CHO
cells are exposed to the drugs is demonstrated in
Figure 2. In this case, the cells were always exposed
to MISO as follows: 5mM MISO, 2h exposure in
hypoxia, 37°C. Bleomycin treatment was always for
1 h at 37°C in hypoxia at the indicated bleomycin
concentrations. If MISO treatment precedes that of
bleomycin, the cell kill was nearly one order of
magnitude larger than if the sequence was reversed.
Bleomycin is approximately equally cytotoxic to
oxic and hypoxic cells. In these studies we limited
our experiments to hypoxic conditions.
The possible existence of potentially lethal
damage (PLD), inflicted by either bleomycin alone
or a bleomycin-MISO combination, was investi-
gated by briefly exposing the cells to hypertonic
solution. This procedure has been commonly used
to demonstrate the existence of PLD in irradiated
cells (Utsumi & Elkind, 1979). It has also been used
to demonstrate the existence of PLD in cells
exposed to MISO in hypoxia (Korbelik et al.,
1982). Figure 3 shows the results of an experiment
where cells were first exposed to bleomycin alone
(50jgml-1, hypoxia, 1 h 370C indicated concen-
trations), or to MISO (5mM, hypoxia, 2h 370C)
followed by bleomycin. Immediately after drug ex-
posure, the cells were washed and plated, or they
were first treated with a hypertonic solution
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Figure 2 Sequence of bleomycin-MISO treatment.
CHO cells were exposed to 5mM MISO, 2h at 370C
in hypoxia. This treatment either preceded (A) or was
followed (V) by exposure of cells to bleomycin (1 h,
37°C in hypoxia). The first drug was washed away
prior to the second drug treatment. Control cells were
treated with bleomycin alone (0). Immediately after
treatment, cells were washed and plated.
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Figure 3 Hypertonic treatment. Cells were treated
with bleomycin alone (0, 0) (50ugmml-', 1 h, 37°C in
hypoxia) or bleomycin followed by MISO treatment
(A, A) (5mM MISO, 2h at 37°C in hypoxia). Cells
were then washed and plated immediately (open
symbols) or were first treated with hypertonic solution
(0.5 MNaCl, phosphate buffer, pH =7.2) for 20min,
before plating. The dashed lines are the same data for
hypertonic treatment on an expanded scale.
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(0.5 MNaCl, phosphate buffer, pH= 7.2) for 20min
at 37°C before plating. The drastic decrease in cell
survival after hypertonic treatment suggests the
presence of a large amount of PLD-like damage in
these cells.
The capacity of cells to repair this damage was
investigated and the results of these experiments are
presented in Figure 4. Cells were always incubated
with 2mM MISO at 37°C in hypoxia for the
indicated times. A sample of cell suspension was
withdrawn at the prescribed time, the cells were
washed free of MISO and the sample was divided
into 3 aliquots. The cells were then exposed to 0,
100 or 300Qugml-1 of bleomycin, for I h at 37°C in
0 2 4 6
Time (h)
Figure 4 MISO-bleomycin treatment. Cells were
exposed to 2mM MISO at 37°C in hypoxia for the
indicated times. They were then washed and further
exposed to either Opgml-1 (0), l00pgml-1 (A), or
300 ig ml-1 (Ol) bleomycin for h at 37°C in hypoxia.
Immediately after treatment, they were washed and
plated. For 2mM MISO, after 5 h at 37°C in hypoxia,
followed by 1h treatment with 100pugml-1 bleomycin
at 37°C in hypoxia, cells were plated immediately after
washing (A) or, they were further incubated in
hypoxia at 37°C for the indicated times, and then
plated (A).
hypoxia. Immediately thereafter, bleomycin was
washed away and the cells were plated.
In the case of the 100 gml-1 bleomycin
exposure, some samples were kept in hypoxia after
the last cell wash before they were plated, in order
to examine repair of PLD damage. Indeed, keeping
cells in hypoxia before plating them resulted in
almost a 100-fold increase in cell survival.
Discussion
The bleomycin-MISO interaction has many
similarities to the radiation-MISO interaction. The
latter is believed to involve different types of PLD
which each modality inflicts on the same target. We
believe that this radiation-MISO interaction is
simply the result of two types of injuries interfering
with each other's respective repair in the same
target (Korbelik et al., 1981, and submitted). We
would like to put forward a hypothesis that the
same mechanism could explain bleomycin-MISO
interaction. Bleomycin induces PLD as can be seen
from the hypertonic treatment effects, Figure 3.
MISO, on its own, has also been shown to induce
PLD (Korbelik et al., 1982, and submitted). The
coffbined treatment of cells with both drugs (in
sequence) enhances the total PLD (Figure 3).
It was shown that keeping cells in hypoxia after
irradiation resulted in increased cell survival
(Korbelik et al., and submitted). This was explained
as repair of PLD. Cells in hypoxia are arrested in
their progression through the cell cycle (Koch et al.,
1973), thus giving them time to repair PLD before
it is fixed by cell progression. We showed that
incubation of cells in hypoxia results in rapid repair
of radiation induced PLD, presumably, and there is
consequently much less interaction with MISO
cytotoxicity (Korbelik et al., and submitted). It is
likely that the initial increase in cell survival after
bleomycin exposure is also an expression of PLD
repair (Figure 1). This is true for cells kept in
hypoxia with or without MISO present. The fact
that the two curves are indistinguishable up to
nearly 3 h, demonstrates that the presence of MISO
(2mM) does not interfere with repair of bleomycin-
induced PLD repair. This is consistent with our
observation that repair of radiation-induced PLD
under hypoxic conditions is not affected by the
presence of MISO (Brown et al., 1981; Korbelik et
al., and submitted). From the data in Figure 1, it
can be estimated that the half time for repair of the
bleomycin-induced damage is -1 h or less. This is
almost double the rate found for MISO-induced
PLD (Korbelik et al., 1982).
It has been shown for bleomycin MISO
combined treatments that the sequences by which
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the two drugs are used is very important (Roizin-
Towle & Hall, 1981 and Figure 2). If bleomycin
preceded MISO treatment, there was much less
effect on cell killing than when MISO treatment
preceded bleomycin. There are at least two possible
explanations for this: if the repair kinetics of
bleomycin-PLD is much faster that those of
MISO-PLD and if repair continues in the presence
of the second drug, then this result would be
expected. Secondly, if bleomycin PLD is induced
more rapidly than MISO PLD, one would again
expect this result. It seems that both repair kinetics
and damage induction are, in fact, faster for
bleomycin. Thus, the importance of the sequence of
treatments with the respective drugs can be
understood on this basis. Roizin-Towle and Hall
(1981) demonstrated that cysteamine plays a
protective role in both the MISO pretreatment
effect on chemotherapeutic agents and in bleomycin
induced cytotoxicity. They suggested that this offers
strong evidence of a free radical involvement in the
mechanism of enhancement of the action of chemo-
therapeutic agents by MISO, as well as in the
cytotoxicity of bleomycin. In our model, free
radicals would have to attack a common target, for
example, DNA. Scavengers of free radicals like
cysteamine would then protect by depleting the free
radicals available to damage the target. It has been
demonstrated that MISO treatment of hypoxic cells
produces various types of DNA damage in cells
(Palcic & Skarsgard, 1978; Wong et al., 1978; Olive,
1979; Taylor et al., 1982; Varghese & Whitmore,
1983). Bleomycin, too, is known to damage DNA
and it has been suggested that DNA damage and
cell survival are closely correlated (Kohn & Ewig,
1976; Clarkson & Humphrey, 1976; Iqbal et al.,
1976; Hurt et al., 1981, 1983; Hurt & Moses, 1984).
We thus propose that the common target for cell
inactivation with these two drugs is DNA, and that
the interaction between the drugs, as measured by
cell survival, is in fact the result of interaction of
different lesions in the DNA molecule.
In in vivo situations, it is possible that these
drugs may be much less effective than these in vitro
results might indicate. -In Figure 4, the repair
kinetics of combined MISO-bleomycin PLD
damage is demonstrated. After treatment, cells were
washed free of drugs and were either plated
immediately or kept in hypoxia for some time
before plating. Further incubation in hypoxia
increased the survival nearly 100-fold. If a MISO-
bleomycin combination were used in tumour
treatments and aimed at chronically hypoxic cells
(or even acutely hypoxic cells), then once the drugs
were removed by metabolism, repair in hypoxia
would greatly diminish their effectiveness. In vivo,
one would expect hypoxic cells to remain hypoxic
for some time after treatment, before being
recruited back into the growth compartment, thus
they would have time to repair much of the
inflicted damage.
It has been demonstrated that hypoxic cells in
vivo can repair radiation-induced PLD (Urano et
al., 1976). This could explain very small additive
effects of bleomycin and MISO combination in vivo
(Stephens et al., 1981; Randhawa et al., 1982).
The MISO-bleomycin interaction reduces the
zero-slope shoulder of the MISO toxicity response
curve, (Figure 4). This effect resembles that of the
radiation-MISO interaction, where it was
demonstrated that cells maintained in normal
growth conditions for long periods of time could
not repair radiation-induced PLD, while in hypoxia
the reverse was true (Korbelik et al., and
submitted). We have not yet examined the time-
course of repair for bleomycin induced PLD under
these two conditions.
Other chemotherapeutic drugs may resemble
bleomycin with respect to interactions arising from
PLD. Preliminary results with actinomycin-D show
close parallels to the results reported here for
bleomycin.
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